David Vlahov, RN, PhD, FAAN

Headshot of David Vlahov
User Profile Photo

David Vlahov, RN, PhD, FAAN

User Profile Name
Dean, UCSF School of Nursing
Professor Emeritus, School of Nursing
User Profile Title
User Profile Email

Biography

Dr. Vlahov is Professor Emeritus at the University of California, San Francisco School of Nursing after serving five years as Dean. He served on the faculty as Professor of Epidemiology at the Johns Hopkins and Columbia Universities, and was Adjunct Professor in Medical Schools at Cornell, Mount Sinai and New York University and the College of Nursing at New York University. He has also served as co-Director of the National Program Office(NPO) for the Robert Wood Johnson Foundation Health and Society Scholars program and currently, the NPO for the Foundation's Evidence for Action program. He brings research expertise in urban health, epidemiology, infectious diseases, substance abuse and mental health. Dr. Vlahov conducted studies of urban populations in Baltimore for over 20 years including several longitudinal cohort studies for which he received the NIH MERIT Award. More recently, Dr. Vlahov led epidemiologic studies in Harlem and the Bronx, which have served as a platform for subsequent individual- and community-level intervention studies and community based participatory research (involving partnerships with residents, community based organizations, academic/ public health departments) to address social determinants of health. This work has contributed information on racial/ethnic disparities in health and approaches to address such disparities. Uniting these interests, Dr. Vlahov became Director of the Center for Urban Epidemiologic Studies at the New York Academy of Medicine He was a Visiting Professor at the Medical School in Belo Horizonte, Brazil to develop their programs in urban health, and has been an expert consultant to the WHO’s Urban Health Center in Kobe, Japan. He served on the New York City Board of Health during the Bloomberg administration. Dr. Vlahov is the editor-in-chief of the Journal of Urban Health, has edited three books on urban health and published over 650 scholarly papers. With colleagues he initiated the International Society for Urban Health (www.isuh.org), serving as its first President. He is a member of the National Academy of Medicine (formerly theInstitute of Medicine) and a Fellow of the American Academy of Nursing. He has served on the Board of Directors for the American Association of Colleges of Nursing and as a member on the National Advisory Council for Nursing Education and Practice at HRSA.
CTSI Profile Bio

Displaying 626 - 650 of 679

  1. Smith AM, Vlahov D, Menon AS, Anthony JC. Terminology for drug injection practices among intravenous drug users in Baltimore. Int J Addict. 1992 Apr; 27(4):435-53.
  2. Margolick JB, Muñoz A, Vlahov D, Solomon L, Astemborski J, Cohn S, Nelson KE. Changes in T-lymphocyte subsets in intravenous drug users with HIV-1 infection. JAMA. 1992 Mar 25; 267(12):1631-6.
  3. Samuels JF, Vlahov D, Anthony JC, Chaisson RE. Measurement of HIV risk behaviors among intravenous drug users. Br J Addict. 1992 Mar; 87(3):417-28.
  4. Graham NM, Nelson KE, Solomon L, Bonds M, Rizzo RT, Scavotto J, Astemborski J, Vlahov D. Prevalence of tuberculin positivity and skin test anergy in HIV-1-seropositive and -seronegative intravenous drug users. JAMA. 1992 Jan 15; 267(3):369-73.
  5. Alcabes P, Vlahov D, Anthony JC. Characteristics of intravenous drug users by history of arrest and treatment for drug use. J Nerv Ment Dis. 1992 Jan; 180(1):48-54.
  6. Alcabes P, Vlahov D, Anthony JC. Correlates of human immunodeficiency virus infection in intravenous drug users: are treatment-program samples misleading? Br J Addict. 1992 Jan; 87(1):47-54.
  7. Vlahov D. HIV-1 infection in the correctional setting. NIDA Res Monogr. 1992; 118:51-61.
  8. Chaisson RE, Taylor E, Margolick JB, Muñoz A, Solomon L, Cohn S, Nelson KE, Vlahov D. Immune serum markers and CD4 cell counts in HIV-infected intravenous drug users. J Acquir Immune Defic Syndr (1988). 1992; 5(5):456-60.
  9. Muñoz A, Vlahov D, Solomon L, Margolick JB, Bareta JC, Cohn S, Astemborski J, Nelson KE. Prognostic indicators for development of AIDS among intravenous drug users. J Acquir Immune Defic Syndr (1988). 1992; 5(7):694-700.
  10. Steinhoff MC, Auerbach BS, Nelson KE, Vlahov D, Becker RL, Graham NM, Schwartz DH, Lucas AH, Chaisson RE. Antibody responses to Haemophilus influenzae type B vaccines in men with human immunodeficiency virus infection. N Engl J Med. 1991 Dec 26; 325(26):1837-42.
  11. Royal W, Updike M, Selnes OA, Proctor TV, Nance-Sproson L, Solomon L, Vlahov D, Cornblath DR, McArthur JC. HIV-1 infection and nervous system abnormalities among a cohort of intravenous drug users. Neurology. 1991 Dec; 41(12):1905-10.
  12. Donahue JG, Nelson KE, Muñoz A, Vlahov D, Rennie LL, Taylor EL, Saah AJ, Cohn S, Odaka NJ, Farzadegan H. Antibody to hepatitis C virus among cardiac surgery patients, homosexual men, and intravenous drug users in Baltimore, Maryland. Am J Epidemiol. 1991 Nov 15; 134(10):1206-11.
  13. Anthony JC, Vlahov D, Nelson KE, Cohn S, Astemborski J, Solomon L. New evidence on intravenous cocaine use and the risk of infection with human immunodeficiency virus type 1. Am J Epidemiol. 1991 Nov 15; 134(10):1175-89.
  14. Vlahov D, Muñoz A, Celentano DD, Cohn S, Anthony JC, Chilcoat H, Nelson KE. HIV seroconversion and disinfection of injection equipment among intravenous drug users, Baltimore, Maryland. Epidemiology. 1991 Nov; 2(6):444-6.
  15. Nelson KE, Vlahov D, Cohn S, Lindsay A, Solomon L, Anthony JC. Human immunodeficiency virus infection in diabetic intravenous drug users. JAMA. 1991 Oct 23-30; 266(16):2259-61.
  16. Celentano DD, Vlahov D, Cohn S, Anthony JC, Solomon L, Nelson KE. Risk factors for shooting gallery use and cessation among intravenous drug users. Am J Public Health. 1991 Oct; 81(10):1291-5.
  17. Solomon L, Frank R, Vlahov D, Astemborski J. Utilization of health services in a cohort of intravenous drug users with known HIV-1 serostatus. Am J Public Health. 1991 Oct; 81(10):1285-90.
  18. Nelson KE, Vlahov D, Cohn S, Odunmbaku M, Lindsay A, Antohony JC, Hook EW. Sexually transmitted diseases in a population of intravenous drug users: association with seropositivity to the human immunodeficiency virus (HIV). J Infect Dis. 1991 Sep; 164(3):457-63.
  19. Vlahov D, Brewer TF, Castro KG, Narkunas JP, Salive ME, Ullrich J, Muñoz A. Prevalence of antibody to HIV-1 among entrants to US correctional facilities. JAMA. 1991 Mar 06; 265(9):1129-32.
  20. Samuels JF, Vlahov D, Anthony JC, Solomon L, Celentano DD. The practice of 'frontloading' among intravenous drug users: association with HIV-antibody. AIDS. 1991 Mar; 5(3):343.
  21. Viscidi RP, Hill PM, Li SJ, Cerny EH, Vlahov D, Farzadegan H, Halsey N, Kelen GD, Quinn TC. Diagnosis and differentiation of HTLV-I and HTLV-II infection by enzyme immunoassays using synthetic peptides. J Acquir Immune Defic Syndr (1988). 1991; 4(12):1190-8.
  22. Vlahov D, Anthony JC, Munoz A, Margolick J, Nelson KE, Celentano DD, Solomon L, Polk BF. The ALIVE study, a longitudinal study of HIV-1 infection in intravenous drug users: description of methods and characteristics of participants. NIDA Res Monogr. 1991; 109:75-100.
  23. Vlahov D, Anthony JC, Celentano D, Solomon L, Chowdhury N. Trends of HIV-1 risk reduction among initiates into intravenous drug use 1982-1987. Am J Drug Alcohol Abuse. 1991; 17(1):39-48.
  24. Gershon RM, Vlahov D. HIV infection risk to health-care workers. Am Ind Hyg Assoc J. 1990 Dec; 51(12):A802-6.
  25. Gershon RM, Vlahov D, Nelson KE. HIV infection risk to nonhealth-care workers. Am Ind Hyg Assoc J. 1990 Dec; 51(12):A807-9.